CLINICAL TRIALS PROFILE FOR VIIBRYD
✉ Email this page to a colleague
All Clinical Trials for viibryd
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01473381 ↗ | Safety and Efficacy of Vilazodone in Major Depressive Disorder | Completed | Forest Laboratories | Phase 4 | 2011-12-01 | The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed dose levels of vilazodone compared to placebo in patients with major depressive disorder. |
NCT01473394 ↗ | Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder | Completed | Forest Laboratories | Phase 4 | 2011-12-01 | The purpose of this study was to further characterize the efficacy, safety, and tolerability of a single fixed dose level of vilazodone compared to placebo in patients with major depressive disorder. |
NCT01573598 ↗ | Safety and Efficacy of Vilazodone in Major Depressive Disorder | Completed | Forest Laboratories | Phase 4 | 2012-04-01 | Safety and Efficacy of Vilazodone in Major Depressive Disorder |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for viibryd
Condition Name
Clinical Trial Locations for viibryd
Trials by Country
Clinical Trial Progress for viibryd
Clinical Trial Phase
Clinical Trial Sponsors for viibryd
Sponsor Name